While some patients report it, it is less typical than recognised effects such as nausea, vomiting or abdominal discomfort
The recommended semaglutide dosing schedule, as per the prescribing information and clinical trials, is as follows: Administer WEGOVY once weekly, on the same day each week, at any time of day, with or without meals Inject subcutaneously in the abdomen, thigh or upper arm (alternate injection site) In 4 week intervals, increase the dose until a dose of 2.4 mg is reached
Evidence indicates that stopping GLP-1 treatment is commonly followed by substantial regain, which reframes these medications as ongoing management of a chronic condition rather than a temporary course
This can be relevant for oral progesterone or oral progestogen, particularly if symptoms suggest reduced effectiveness
They act as messengers, telling different systems in your body what to do and when to do it